1.3m switched to new ARV, but weight gain is a concern

1.3m switched to new ARV, but weight gain is a concern

Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.

Read More

The era of viral load is here

By Sharonann Lynch – Viral load testing measures the amount of HIV virus (HIV RNA) in a person’s blood. It is the optimal method for identifying antiretroviral therapy (ART) treatment failure (defined as an HIV viral load greater than 1000 copies/mL), because it is more sensitive and has a higher positive predictive value than CD4 cell count and other clinical indicators.

Read More